Between Well-being and Productivity, Psychedelics Enter the Corporate World's Radar

Amidst pressure for results, productivity, and innovation, a still controversial trend is beginning to emerge in high-level corporate environments: the use of psychedelics by executives as a tool for well-being, self-awareness, and performance.  

According to the Cañamo website, substances like psilocybin and ketamine are being associated with programs, retreats, and experiences focused on leadership development and mental health.

The proposal is based on the idea that psychedelic experiences, when structured and supervised, can help reduce stress, stimulate creativity, and enhance decision-making abilities, skills increasingly valued in leadership positions. 

In a context marked by high burnout rates, the discourse of well-being is now walking hand in hand with the pursuit of productivity.

However, the advancement of this market exposes contradictions. While executives have access to sophisticated experiences, often in countries with greater legal flexibility, the use of these substances remains criminalized in most parts of the world. The practice, therefore, sparks debates on privilege, inequality of access, and selectivity in law enforcement.

From a scientific standpoint, experts warn of the need for caution. Despite the growing academic interest in psychedelics, especially in the field of mental health, conclusive evidence regarding their direct effects on productivity and professional performance is still limited.

With information from Cañamo.Net.